Experimental models of stroke result in elevated levels of complement components (C1q, C3a, C5a) in the brain [23, 36, 106, 228, 229] and upregulation of C1q mRNA in microglia [23] and C5 mRNA in neurons [36]. This evidence concerns the gene C3 and stroke disorder.